Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study. [electronic resource]
Producer: 20120904Description: 587-93 p. digitalISSN:- 1708-8283
- Action Potentials -- drug effects
- Botulinum Toxins, Type A -- therapeutic use
- Cerebral Palsy -- complications
- Child
- Child, Preschool
- Electromyography
- Equinus Deformity -- drug therapy
- Female
- Humans
- Leg -- innervation
- Male
- Muscle, Skeletal -- drug effects
- Neuromuscular Agents -- therapeutic use
- Prospective Studies
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.